Pegylated Interferon



Indications and Reactions:

Role Indications Reactions
Primary
Chronic Hepatitis C 100.0%
Tooth Fracture 100.0%
Secondary
Hepatitis C 55.6%
Product Used For Unknown Indication 17.9%
Chronic Hepatitis C 8.2%
Immunosuppressant Drug Therapy 2.2%
Medical Diet 2.2%
Chronic Hepatitis 1.5%
Hypertension 1.5%
Pyrexia 1.5%
Antiviral Treatment 1.1%
Hepatitis C Virus Test 1.1%
Headache 0.7%
Hiv Infection 0.7%
Influenza Like Illness 0.7%
Insomnia 0.7%
Metastatic Renal Cell Carcinoma 0.7%
Nasal Congestion 0.7%
Oral Candidiasis 0.7%
Seasonal Allergy 0.7%
Wheezing 0.7%
Autoimmune Hepatitis 0.4%
Rash 10.2%
Thrombocytopenia 8.2%
Pyrexia 6.1%
Renal Impairment 6.1%
Viral Load Increased 6.1%
Vomiting 6.1%
Drug Reaction With Eosinophilia And Systemic Symptoms 4.1%
Myalgia 4.1%
Myositis 4.1%
Oedema Peripheral 4.1%
Palpitations 4.1%
Porphyria Non-acute 4.1%
Proctalgia 4.1%
Pruritus 4.1%
Rash Generalised 4.1%
Rash Pruritic 4.1%
Tachycardia 4.1%
Visual Acuity Reduced 4.1%
Weight Decreased 4.1%
Wound Secretion 4.1%
Concomitant
Hepatitis C 66.8%
Product Used For Unknown Indication 18.3%
Chronic Hepatitis C 2.6%
Hiv Infection 1.7%
Hypertension 1.7%
Acquired Immunodeficiency Syndrome 1.3%
Diabetes Mellitus 1.3%
Back Pain 0.9%
Eye Disorder 0.9%
Immunosuppression 0.9%
Anaemia 0.4%
Drug Use For Unknown Indication 0.4%
Dry Skin 0.4%
Myelofibrosis 0.4%
Myeloproliferative Disorder 0.4%
Nausea 0.4%
Prophylaxis 0.4%
Pruritus 0.4%
Rash 22.7%
Thrombocytopenia 9.1%
Vomiting 9.1%
Neutropenia 6.8%
Anaemia 4.5%
Haemoglobin Decreased 4.5%
Myocardial Infarction 4.5%
Pruritus Generalised 4.5%
Rash Generalised 4.5%
Visual Impairment 4.5%
White Blood Cell Count Decreased 4.5%
Condition Aggravated 2.3%
Confusional State 2.3%
Depressive Symptom 2.3%
Drug Dose Omission 2.3%
Drug Reaction With Eosinophilia And Systemic Symptoms 2.3%
Feeling Abnormal 2.3%
Haematocrit Decreased 2.3%
Haematuria 2.3%
Headache 2.3%